Clinical trial · Interventional
Therapeutic Play on Pain Tolerance and Emotion Regulation in Children
Therapeutic Play on Pain Tolerance and Emotion Regulation in Children Receiving Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The research is a randomized controlled experimental study. The population of the research will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana City Training and Research Hospital between 19.05.2024 and 19.05.2025. Therapeutic play sessions will occur over a 4-week period during chemotherapy treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Therapeutic Play | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- intervention
- description
- Therapeutic play sessions will be organized twice a week for 4 weeks during chemotherapy treatment for children diagnosed with acute lymphoblastic leukemia in the intervention group.
- interventionNames
- Behavioral: Therapeutic Play
- type
- NO_INTERVENTION
- label
- control
- description
- Routine treatment will be applied to children in the control group receiving chemotherapy during their treatment.
Primary outcomes (2)
- measure
- Pain Tolerance Scale for Children with Cancer
- timeFrame
- 12 months
- description
- The scale was created to develop a tool to measure psychological acceptance in children experiencing pain during cancer treatment. The test version of the scale was conducted on children between the ages of 7 and 18 who were receiving cancer treatment. The Turkish reliability and validity study of the scale was conducted and it was found suitable for use in Turkish children with cancer. The scale is a 7-point Likert type scale consisting of 20 items (0 = strongly disagree and 6 = strongly agree). Some items in the scale (1, 2, 3, 5, 6, 7, 8, 9, 11, 13, 14, 15, 16, 18, 20 items) are reverse coded. The minimum score to be obtained from the scale is 0 and the maximum score is 120. Increasing scale scores indicate an increase in the level of acceptance.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Between the ages of 10-18 * Diagnosed with acute lymphoblastic leukemia * Those receiving chemotherapy treatment * Children who do not have a chronic disease other than the diagnosis of the disease in question Exclusion Criteria: * Under 10 years of age or over 18 years of age * Diagnosed other than acute lymphoblastic leukemia * Not receiving chemotherapy treatment * Children with chronic diseases other than the diagnosis of the disease in question
References
Publications (0)
Data not yet available